Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Other Accumulated Expenses (2020 - 2025)

PROCEPT BioRobotics has reported Other Accumulated Expenses over the past 6 years, most recently at $10.1 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $10.1 million for Q4 2025, up 24.53% from a year ago — trailing twelve months through Dec 2025 was $10.1 million (up 24.53% YoY), and the annual figure for FY2025 was $10.1 million, up 24.53%.
  • Other Accumulated Expenses for Q4 2025 was $10.1 million at PROCEPT BioRobotics, up from $8.2 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for PRCT hit a ceiling of $10.1 million in Q4 2025 and a floor of $2.8 million in Q3 2021.
  • Median Other Accumulated Expenses over the past 5 years was $7.8 million (2023), compared with a mean of $7.1 million.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 133.08% in 2021 and later decreased 15.4% in 2023.
  • PROCEPT BioRobotics' Other Accumulated Expenses stood at $4.6 million in 2021, then skyrocketed by 62.07% to $7.5 million in 2022, then decreased by 15.4% to $6.3 million in 2023, then increased by 28.03% to $8.1 million in 2024, then rose by 24.53% to $10.1 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $10.1 million (Q4 2025), $8.2 million (Q3 2025), and $9.7 million (Q2 2025) per Business Quant data.